Dr Reddy’s reports Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore

DRL on Friday reported a consolidated net profit of Rs 20 crore in the third quarter against a loss of Rs 569.7 crore in the year-before period.

DRL said the Q3 results were impacted primarily due the non-recognition of deferred tax assets on impairment.

The firm posted a 12 per cent year-on-year growth in revenues to Rs 4,930 crore and a 10 per cent YoY growth in Ebitda to Rs 1,185 crore while the Ebitda margin stood at 24 per cent.

The US business grew by 9 per cent YoY to Rs 1,739 crore while India posted an increase by 26 per cent YoY to Rs 959 crore.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor